COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab

被引：0
|
作者：
Anne H. Cross
Silvia Delgado
Mario Habek
Maria Davydovskaya
Brian J. Ward
Bruce A. C. Cree
Natalia Totolyan
Ratnakar Pingili
Linda Mancione
Xixi Hu
Roseanne Sullivan
Wendy Su
Ronald Zielman
Ayan Das Gupta
Xavier Montalban
Kevin Winthrop
机构：
[1] Washington University,Department of Neurology
[2] University of Miami Miller School of Medicine,Infectious Diseases Division
[3] University Hospital Center Zagreb,UCSF Weill Institute for Neurosciences, Department of Neurology
[4] University of Zagreb,Department of Neurology
[5] School of Medicine,Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat)
[6] Moscow State Public Healthcare InsCity Clinical Hospital 24,undefined
[7] Research Institute of the McGill University Health Centre,undefined
[8] University of California San Francisco,undefined
[9] First Saint Petersburg State Medical University,undefined
[10] Novartis Pharmaceuticals Corporation,undefined
[11] Novartis Pharma B.V.,undefined
[12] Novartis Healthcare Private Limited,undefined
[13] Hospital Universitari Vall d’Hebron,undefined
[14] School of Public Health at Oregon Health and Science University,undefined
来源：
Neurology and Therapy | 2022年 / 11卷
关键词：
ALITHIOS; Anti-CD20 therapy; B-cell therapy; COVID-19; Ofatumumab; Post-marketing; Relapsing multiple sclerosis; SARS-CoV-2; Vaccination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：741 / 758
页数：17
相关论文
共 50 条
  • [21] COVID-19 outcomes in persons with multiple sclerosis treated with rituximab
    Iyer, Rajesh B.
    Raghavendra, S.
    Nooraine, Javeria M.
    Jaychandran, R.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57
  • [22] Hypogammaglobulinemia, infections and COVID-19 in people with multiple sclerosis treated with ocrelizumab
    Habek, Mario
    Piskac, Dominik
    Gabelic, Tereza
    Barun, Barbara
    Adamec, Ivan
    Skoric, Magdalena Krbot
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 62
  • [23] COVID-19 vaccination uptake in people with multiple sclerosis compared to the general population
    Mayer, Dijana
    Barun, Barbara
    Lazibat, Karla
    Lasic, Slava
    Adamec, Ivan
    Gabelic, Tereza
    Skoric, Magdalena Krbot
    Habek, Mario
    ACTA NEUROLOGICA BELGICA, 2023, 123 (06) : 2269 - 2275
  • [24] COVID-19 vaccination in people with multiple sclerosis, real-life experience
    Alroughani, Raed
    Al-Hashel, Jasem
    Abokalawa, Fathi
    AlMojel, Malak
    Ahmed, Samar Farouk
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 220
  • [25] Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination
    Zaloum, Safiya A.
    Wood, Callum H.
    Tank, Pooja
    Upcott, Matthew
    Vickaryous, Nicola
    Anderson, Valerie
    Baker, David
    Chance, Randy
    Evangelou, Nikos
    George, Katila
    Giovannoni, Gavin
    Harding, Katharine E.
    Hibbert, Aimee
    Ingram, Gillian
    Jolles, Stephen
    Kang, Angray S.
    Loveless, Samantha
    Moat, Stuart J.
    Richards, Aidan
    Robertson, Neil P.
    Rios, Francesca
    Schmierer, Klaus
    Willis, Mark
    Dobson, Ruth
    Tallantyre, Emma C.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (08) : 979 - 989
  • [26] COVID-19 vaccination uptake in people with multiple sclerosis compared to the general population
    Dijana Mayer
    Barbara Barun
    Karla Lazibat
    Slava Lasić
    Ivan Adamec
    Tereza Gabelić
    Magdalena Krbot Skorić
    Mario Habek
    Acta Neurologica Belgica, 2023, 123 : 2269 - 2275
  • [27] Case report of relapsing COVID-19 infection in a patient with multiple sclerosis treated with ocrelizumab
    Pazderkova, J.
    Bartos, H.
    Dlouhy, P.
    Vachova, M.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2021, 84 (01) : 92 - 94
  • [28] Ofatumumab for relapsing forms of multiple sclerosis
    Gajofatto, Alberto
    Orlandi, Riccardo
    DRUGS OF TODAY, 2022, 58 (01) : 9 - 21
  • [29] Risk of COVID-19 after vaccination among people with multiple sclerosis who are treated with disease modifying therapies
    Golan, D.
    Lavi, I.
    Bloch, S.
    Saliba, W.
    Awni, Y.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 874 - 874
  • [30] Clinical features and outcomes of COVID-19 despite SARS-CoV-2 vaccination in people with multiple sclerosis
    Rose, Deja R.
    Mahadeen, Khmad Z.
    Carlson, Alise K.
    Planchon, Sarah M.
    Sedlak, Jennifer
    Husak, Scott
    Bermel, Robert A.
    Cohen, Jeffrey A.
    Moss, Brandon P.
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2021, 7 (04)
12345